Lonza plans to more than double its U.S. footprint of CDMO sites by agreeing to acquire five such sites in the U.S. from Merck KGaA, Darmstadt, Germany, in a deal the companies would only say was ...

Study findings showed that the cancer cells organize themselves according to a consistent, predictable structural pattern across different patients.

Researchers say findings establish HOX genes as potential therapeutic targets for enhancing bone regeneration.

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections.

The findings show precise correction of the SCD mutation in the β-globin gene in three SCD patients as well as restored expression of adult hemoglobin (HbA).

Differing apheresis practices at collection sites have a significant impact on samples and, therefore, the quality of cell ...

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...

In this GEN eBook readers will discover how epigenomic insights are improving every stage of the drug discovery pipeline, ...

Many of the blood proteins that could flag neurodegeneration are so scarce that standard assays barely register them. A new UK Biobank study will test whether an ultrasensitive platform can pick them ...

Findings may offer insights into disorders associated with dysregulated forgetting, including dementia and PTSD.

The FDA has set a May 1 target action date for uniQure’s Huntington’s disease gene therapy candidate ifezuntirgene inilparvovec, after accepting the company’s Biologics License Application (BLA) under ...

Study findings reframe pulmonary hypertension as a multi-organ inflammatory disorder and point to potential diagnostic, prognostic targets.